Your browser doesn't support javascript.
loading
Effect of moxifloxacin combined with cefotaxime compared to cefotaxime-gentamicin combination on prevention of white matter damage associated with Escherichia coli sepsis in neonatal rats.
Antimicrob Agents Chemother ; 55(7): 3567-9, 2011 Jul.
Article in En | MEDLINE | ID: mdl-21502635
ABSTRACT
Relative to the cefotaxime-gentamicin combination, the moxifloxacin-cefotaxime combination significantly reduced microglial activation and immature oligodendrocyte cell death and delayed myelination in the developing white matter of neonatal rats with experimental Escherichia coli sepsis. These neuroprotective effects were not due to differences in in vivo bactericidal activities or in the systemic inflammatory responses and could be related to the intrinsic immunomodulatory properties of moxifloxacin. Molecular mechanisms underlying the neuroprotective effect of moxifloxacin remain to be elucidated.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Quinolines / Aza Compounds / Gentamicins / Cefotaxime / Sepsis / Escherichia coli Infections / Leukoencephalopathies / Anti-Bacterial Agents Type of study: Risk_factors_studies Limits: Animals Language: En Journal: Antimicrob Agents Chemother Year: 2011 Type: Article Affiliation country: France

Full text: 1 Database: MEDLINE Main subject: Quinolines / Aza Compounds / Gentamicins / Cefotaxime / Sepsis / Escherichia coli Infections / Leukoencephalopathies / Anti-Bacterial Agents Type of study: Risk_factors_studies Limits: Animals Language: En Journal: Antimicrob Agents Chemother Year: 2011 Type: Article Affiliation country: France